| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $51 ...
Scotiabank analyst Nicholas Yulico maintains American Healthcare REIT (NYSE:AHR) with a Sector Outperform and raises the pri...
Keybanc analyst Austin Wurschmidt maintains American Healthcare REIT (NYSE:AHR) with a Overweight and raises the price targe...
RBC Capital analyst Michael Carroll maintains American Healthcare REIT (NYSE:AHR) with a Outperform and raises the price tar...
Citizens analyst Aaron Hecht maintains American Healthcare REIT (NYSE:AHR) with a Market Outperform and raises the price tar...
American Healthcare REIT (NYSE:AHR) raises FY2025 FFO guidance from $1.64-$1.68 to $1.69-$1.72 vs $1.67 analyst estimate..
American Healthcares (NYSE:AHR) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0....